Hyperfine, Inc. ( HYPR ) NASDAQ Global Market

Cena: 0.72 ( -2.59% )

Aktualizacja 06-13 22:00
NASDAQ Global Market
Branża: Medical - Devices

Notowania:


Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Devices
Zatrudnienie: 131
Giełda: NASDAQ Global Market
Ilość akcji w obrocie: 84%
Ilość akcji: 56 544 300
Debiut giełdowy: 2021-01-28
WWW: https://hyperfine.io
CEO: Ms. Maria Sainz
Adres: 351 New Whitfield Street
Siedziba: 06437 Guilford
ISIN: US44916K1060
Opis firmy:

Hyperfine, Inc. zapewnia produkty obrazowania, monitorowania i rezonansu magnetycznego. Oferuje przenośny system obrazowania MR, aby zaspokoić niezaspokojoną potrzebę w obrazowaniu medycznym w punkcie opieki poprzez kombinację usług sprzętowych i oprogramowania. Firma została zarejestrowana w 2014 roku i ma siedzibę w Guilford, Connecticut.

Wskaźniki finansowe
Kapitalizacja (USD) 56 200 369
Aktywa: 69 386 000
Cena: 0.72
Wskaźnik Altman Z-Score: -2.8
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: -1.3
Ilość akcji w obrocie: 84%
Średni wolumen: 2 966 552
Ilość akcji 77 839 846
Wskaźniki finansowe
Przychody TTM 13 255 000
Zobowiązania: 11 064 000
Przedział 52 tyg.: 0.533 - 1.9
Piotroski F-Score: 3
Słaby (niska jakość finansowa)
EPS: -0.5
P/E branży: 26.8
Beta: 0.844
Raport okresowy: 2025-08-06
WWW: https://hyperfine.io
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Ms. Maria Sainz Chief Executive Officer, President & Director 847 000 1966
Mr. Brett Hale Chief Administrative Officer, Chief Financial Officer, Chief Compliance Officer, Treasurer & Corporate Secretary 580 267 1974
Dr. Thomas Teisseyre Ph.D. Chief Operating Officer 519 239 1984
Dr. Jonathan M. Rothberg Ph.D. Founder & Vice Chairman 50 000 1964
Mr. R. Scott Huennekens CPA, M.B.A. Executive Chairman 124 889 1964
Mr. Chip Truwit FACR, M.D. Vice President of Scientific Affairs 0 0
Wiadomości dla Hyperfine, Inc.
Tytuł Treść Źródło Aktualizacja Link
Hyperfine, Inc. (HYPR) Q1 2025 Earnings Call Transcript Hyperfine, Inc. (NASDAQ:HYPR ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Yuan Zhi - B. Riley Securities Operator Thank you for standing by. seekingalpha.com 2025-05-14 00:18:12 Czytaj oryginał (ang.)
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Lags Revenue Estimates Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.12 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.14 per share a year ago. zacks.com 2025-05-13 22:30:34 Czytaj oryginał (ang.)
Hyperfine, Inc. Reports First Quarter 2025 Financial Results GUILFORD, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2025 financial results and provided a business update. globenewswire.com 2025-05-13 20:05:00 Czytaj oryginał (ang.)
Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025 GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the first quarter 2025 on Tuesday, May 13, 2025. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A live audio webcast and an archive of the r. businesswire.com 2025-04-29 20:28:00 Czytaj oryginał (ang.)
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices GUILFORD, Conn.--(BUSINESS WIRE)--Study examines clinical utility and patient experience of AI-powered portable MRI in neurology offices. businesswire.com 2025-04-15 20:00:00 Czytaj oryginał (ang.)
HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging Hyperfine partners with NVIDIA to integrate advanced AI into its Swoop MRI system, aiming to transform neuroimaging with faster and more accessible brain scan solutions. zacks.com 2025-03-18 15:31:05 Czytaj oryginał (ang.)
Hyperfine, Inc. (HYPR) Q4 2024 Earnings Call Transcript Hyperfine, Inc. (NASDAQ:HYPR ) Q4 2024 Results Conference Call March 17, 2025 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Brandon Carney - B. Riley Young Li - Jefferies Operator Ladies and gentlemen, thank you for standing by. seekingalpha.com 2025-03-17 21:43:03 Czytaj oryginał (ang.)
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2024 financial results and provided a business update. globenewswire.com 2025-03-17 18:05:00 Czytaj oryginał (ang.)
Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable Hyperfine, Inc. HYPR shares are surging on Monday. benzinga.com 2025-03-17 14:02:05 Czytaj oryginał (ang.)
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. will report financial results for the fourth quarter and full year 2024 on Monday, March 17, 2025. businesswire.com 2025-03-04 18:05:00 Czytaj oryginał (ang.)
Hyperfine Announces $6.0 Million Registered Direct Offering GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 4,511,278 shares of the Company's Class A common stock and warrants to purchase up to 4,511,278 shares of Class A common stock. Each share of Class A common stock and accompanying warrant were sold together at a combined offering price of $1.33 in a registered direct offering. The warrants have an e. businesswire.com 2025-02-11 10:02:00 Czytaj oryginał (ang.)
Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR #aipowered--Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for stroke diagnosis. businesswire.com 2025-02-06 18:05:00 Czytaj oryginał (ang.)
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces global expansion of commercial operations into Turkey, Israel and Saudi Arabia to support Swoop® system expansion plans. businesswire.com 2024-12-17 11:00:00 Czytaj oryginał (ang.)
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals GUILFORD, Conn.--(BUSINESS WIRE)--Strategic appointments position Hyperfine to drive the adoption of the Swoop® system in hospital settings and expand into the office setting. businesswire.com 2024-12-03 11:00:00 Czytaj oryginał (ang.)
Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript Hyperfine, Inc. (NASDAQ:HYPR ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and CEO Brett Hale - Chief Administrative Officer and CFO Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon. seekingalpha.com 2024-11-12 21:39:06 Czytaj oryginał (ang.)
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago. zacks.com 2024-11-12 20:42:18 Czytaj oryginał (ang.)
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced third quarter 2024 financial results and provided a business update. globenewswire.com 2024-11-12 18:05:00 Czytaj oryginał (ang.)
Hyperfine Announces European Launch with CE Approval GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces CE approval of its latest generation of AI-powered Swoop® system software under the European Medical Device Regulation. businesswire.com 2024-11-07 11:00:00 Czytaj oryginał (ang.)
HYPR Achieves Positive Swoop System Data for ECMO: Stock to Rise? Hyperfine announces a publication on using the Swoop system for patients on ECMO support. The study showed the safety of using an ultra-low-field portable brain MRI on patients undergoing ECMO. zacks.com 2024-10-02 15:06:10 Czytaj oryginał (ang.)
Favorable Data on Swoop Portable MRI Likely to Support Hyperfine Stock Compared to conventional MRI, which takes an average of 27.7 hours, the Swoop system of HYPR operates with a median time-to-scan of 2.5 hours. zacks.com 2024-09-26 15:48:14 Czytaj oryginał (ang.)
Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care PARIS--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the presentation of interim data supporting the role portable ultra-low-field MRI can play in acute stroke workup in a hospital emergency department setting. The findings from the study, titled Interim Analysis from Single Centre Observational Study. businesswire.com 2024-09-23 13:44:00 Czytaj oryginał (ang.)
Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced a collaboration with the Medical University of South Carolina to assess the brains of astronauts before and after embarking on the Polaris Dawn mission. Researchers will utilize the Swoop® Portable MR Imaging® system at a SpaceX facility in. businesswire.com 2024-09-11 12:05:00 Czytaj oryginał (ang.)
Hyperfine, Inc. to Participate in Upcoming Investor Conferences GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming H.C. Wainwright 26th Annual Global Investment Conference. Members of management are scheduled to present on Monday, September 9, 2024, at 7:00 am ET. Management will also be hosting in-person meetings at the. businesswire.com 2024-08-28 20:05:00 Czytaj oryginał (ang.)
Hyperfine, Inc. (HYPR) Q2 2024 Earnings Call Transcript Hyperfine, Inc. (NASDAQ:HYPR ) Q2 2024 Earnings Call August 8, 2024 4:30 PM ET Company Participants Marissa Bych - Investor Relations Maria Sainz - President and Chief Executive Officer Brett Hale - Chief Administrative Officer and Chief Financial Officer Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon, and welcome to Hyperfine's Second Quarter 2024 Earnings Conference Call. seekingalpha.com 2024-08-09 08:15:31 Czytaj oryginał (ang.)
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Tops Revenue Estimates Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago. zacks.com 2024-08-08 23:20:33 Czytaj oryginał (ang.)
Hyperfine's (HYPR) Swoop System Gets New FDA-Cleared Software Hyperfine (HYPR) announces the receipt of FDA clearance for its ninth-generation AI-powered Swoop system software. zacks.com 2024-07-18 17:31:34 Czytaj oryginał (ang.)
Hyperfine (HYPR) to Release ACTION PMR Study Data for Swoop Hyperfine (HYPR) is set to release study data in August 2024, showing the value of the Swoop system in enabling critical stroke treatment choices in urgent care settings. zacks.com 2024-07-16 14:26:52 Czytaj oryginał (ang.)
Hyperfine (HYPR) Inks New Partnerships to Expand in Europe Hyperfine (HYPR) announces that it has signed agreements with experienced and accomplished distributors in Germany, Austria, Switzerland, and key Nordic markets for its Swoop, a portable MRI system. zacks.com 2024-07-11 14:16:12 Czytaj oryginał (ang.)
Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024 GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to host analyst and investor education webcast with clinical and brain imaging experts on June 25, 2024. businesswire.com 2024-06-03 20:05:00 Czytaj oryginał (ang.)
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These are Vita Coco Company (COCO), AMC Entertainment (AMC), Hyperfine (HYPR), Aptevo Therapeutics (APVO) and CLEAR Secure (YOU). zacks.com 2024-05-28 13:21:08 Czytaj oryginał (ang.)
Hyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to India GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. continues global expansion by entering into distribution partnership with Radiosurgery Global, Ltd. to bring Swoop® system to India. businesswire.com 2024-05-28 13:00:00 Czytaj oryginał (ang.)
The Dollar Menu Portfolio: 7 Penny Stocks to Buy With Spare Change If you have some spare change jingling in your pocket, it might be worth considering investing that money in penny stocks with good upside potential. The penny stocks on this list are each worth less than $1 as of writing, and I believe many of them could be multibaggers if the stars align favorably. investorplace.com 2024-05-24 10:00:00 Czytaj oryginał (ang.)